Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Cost of Revenue (2018 - 2025)

Viemed Healthcare's Cost of Revenue history spans 8 years, with the latest figure at $32.1 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 30.63% year-over-year to $32.1 million; the TTM value through Dec 2025 reached $114.8 million, up 26.1%, while the annual FY2025 figure was $114.8 million, 26.1% up from the prior year.
  • Cost of Revenue reached $32.1 million in Q4 2025 per VMD's latest filing, up from $30.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $32.1 million in Q4 2025 to a low of $9.8 million in Q2 2021.
  • Average Cost of Revenue over 5 years is $18.7 million, with a median of $17.9 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: tumbled 42.26% in 2021, then skyrocketed 33.69% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $12.3 million in 2021, then rose by 18.8% to $14.6 million in 2022, then grew by 27.48% to $18.6 million in 2023, then soared by 31.83% to $24.6 million in 2024, then skyrocketed by 30.63% to $32.1 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Cost of Revenue are $32.1 million (Q4 2025), $30.6 million (Q3 2025), and $26.3 million (Q2 2025).